CEO: Jack A. Khattar

Sector: Healthcare

Exchange: NASDAQ Global Market

Country: USA

Description: Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders.


Key numbers

Market Capitalization:1158383040
Shares Outstanding: 52463000
Float: 50702656.498
Next Earning Date:2020-03-11
TTm EPS: 2.0208
TTm Dividend Rate:
200 days moving average:31.98
50 days moving average: 26.45
One day percent Change: -0.82



2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,